During the Period 2016-2019, Global Cancer Vaccines Market to Grow at a CAGR of 27.24%

ResearchMoz presents this most up-to-date research on Global Cancer Vaccines Market 2015-2019.

About Cancer Vaccines

Cancer vaccines are biological preparations that stimulate or strengthen a person’s immune system against cancer. Cancer vaccines are usually administered intravenously. They can be used in both adults and children. The vaccines can be broadly classified into two: prophylactic and therapeutic vaccines. Prophylactic vaccines are used for the prevention of cancer, whereas therapeutic vaccines are used for treatment of cancer.

Technavio’s analysts forecast the global cancer vaccines market to grow at a CAGR of 27.24% over the period 2014-2019.

Covered :

This report covers the present scenario and the growth prospects of the global cancer vaccines market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various therapeutic and prophylactic cancer vaccines.

This report covers the present scenario and the growth prospects of the global cancer vaccines market for the period 2015-2019 in the following three regions:

Americas: The principal countries focused upon in this region are the US, Canada, Mexico, and Brazil
EMEA: The principal countries focused upon in this region are the UK; Germany; Italy; France; Spain and Middle Eastern and African countries such as Israel, South Africa, Egypt, Sudan, Kuwait, Saudi Arabia, Qatar, and UAE
APAC: The principal countries focused upon in this region are Japan, China, Australia, Singapore, South Korea, and India. APAC is one of the major markets that is untapped by the leading vendors

The report also presents the vendor landscape and a corresponding detailed analysis of the top vendors in the market. In addition, it discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends that are emerging in the market.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=289682

Technavio’s report, Global Cancer Vaccines Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, EMEA, and APAC; it also covers the global cancer vaccines market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

Americas
APAC
EMEA

Key Vendors

Dendreon
GlaxoSmithKline
Merck

Other Prominent Vendors

Aduro BioTech
Advantagene
Advaxis
Agenus
AlphaVax
Altor BioScience
Amgen
Antigen Express
Argos Therapeutics
AVAX Technologies
Bavarian Nordic
Biothera
Bristol-Myers Squibb
Celldex Therapeutics
Cel-Sci
CureVac
Cytos

For More Information Kindly Contact:

ResearchMoz
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG

Leave a Reply

Designed by CyFocus.com
Powered by CyFocus.net